A nationwide clinical trial is now enrolling adult patients to help evaluate the safety and effectiveness of an oral medication as a potential new treatment option for patients with Crohn's Disease and Anemia.

What is anemia?

 In people with anemia, blood does not carry enough oxygen throughout the body. For people living with Crohn’s Disease, anemia is the most common issue to occur outside of the digestive tract.  

Want to learn more about this study? 

 Call (888) 533-9928 to speak to a study representative. 

Submit

See if You Qualify

What are the causes of anemia?

Anemia is common in people with Crohn’s disease because of internal bleeding, poor iron absorption, and underlying inflammation.

 Why are new treatments being developed for anemia?

Some patients are dissatisfied with iron therapy for anemia because oral iron is often poorly absorbed and also has the potential to cause gastrointestinal side effects. Intravenous iron is another treatment option, but it requires one or more visits to a doctor’s office or hospital.


You may be able to take part in this clinical trial if you:

  • Are 18-70 years old
  • Have been diagnosed with Crohn's disease
  • Have untreated anemia, or are willing to discontinue current anemia treatment for the duration of the study

This study consists of 6 study visits over an 8 week duration. You will be monitored carefully by a team of doctors and study coordinators. All study-related medications and assessments will be provided to you at no-cost. You are allowed to continue taking your current medications for Crohn’s disease with the exception of medication specifically for treatment of anemia (e.g. oral iron, IV iron). Qualified participants with Crohn’s and Anemia will be compensated for time and travel.

Are you living with Crohn's Disease and Anemia?

Are you living with Crohn's Disease and Anemia?

See If You QualifySee If You Qualify
Fix the following errors:
Hide